1 / 21

Lipidomics in Cell Regulation

Lipidomics in Cell Regulation. Lars I Hellgren Associate Professor February 24 th , 2012. Learning objectives. After this lecture you should be able to: -Describe the major types of lipids - Describe the main functions of lipids in the cell

tymon
Download Presentation

Lipidomics in Cell Regulation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Lipidomics in Cell Regulation Lars I Hellgren Associate Professor February 24th, 2012

  2. Learning objectives Afterthislectureyoushouldbeable to: -Describe the major types of lipids - Describe the mainfunctions of lipids in the cell - Describe at leasttwomechanisms of action by whichlipidsregulatecell-metabolism or cell- development

  3. Outline • Why must webother- Relation betweenlipid – patterns and human disease • What is a lipid– Differerentlipid types. • How doeslipidsaffectcellularregulation? • Effects in membranes • Direct effects on enzymes • Effectsthroughlipid receptors • Lipidpathways Whatdetermines the lipidome? • Interpretting the lipidome

  4. Lipids and Human Health • Cardiovasculardiseases– Stronglylinked to levels of differentfattyacids and lipidmetabolism in the arteries, in the blood and in the heart • Insulin resistance/ Type-2 diabetes – Stronglylinked to concentration of certainlipids and lipidmetabolism in skeletal muscles, adipose tissue, the liver and insulin producingb-cells in the pancreas • Severalrheumaticdiseases– Stronglylinked to the concentration of certainfattyacids • Many cancer forms – Stronglylinked to the metabolism of sphingolipids, such as ceramide and sphingosine-1-P

  5. Lipids – someexamples Phosphoglyceride Fattyacids Triacylglycerol R = fattyacids Ganglioside GM2

  6. So, what´s a lipid ? Someexamples from the literature • ”Naturallyoccurringcompounds, which have in common a readysolubility in organic solvents and lowsolubiltiy in water” • ”Hydrophobic or amphipathic small moleculesthatmayoriginateentirely or in part by carbanion-basedcondensations of thioesters (fattyacids, polyketides, etc.) and/or by carbocation-basedcondensations of isoprene units (prenols, sterols, etc.)” Fahyet al. (J. Lipid Res., 46, 839-862 (2005)) • ”Lipidsarefattyacids and their derivatives, and substancesrelatedbiosynthetically or functionally to thesecompounds. ” Bill Cristie on www.lipidlibrary.co.uk

  7. Lipids – someexamples Glycerophospholipids Fattyacids Triacylglycerol R = fattyacids Ganglioside GM2

  8. Major Types of Lipids Glycerophospholipids Fattyacids Sphingolipids Sterols Sphingosine Ceramide cholesterol Sphingomyelin cholesterolesters Glycosphingolipids

  9. Lipidstructures – Fattyacids • Most abundant: C14 – C24 • 0 – 6 double bonds • saturated, monounsaturated, polyunsaturated • Only minute amounts are free. • Normally constitutents of other lipids; triacylglycerols, phosphoglycerides, sphingolipidsetc • Certain FA are important regulators of gene-transcription in glucose and lipid metabolism • FA – metabolites are important signalling molecules involved in: • Induction and resultion of inflammation (f. ex. prostaglandins and resolvins) • Appetite regulation (endocannabinoids) C16:0 C18:1 Arachidonicacid (C20:4; n-6) Docosahexaenoicacid (DHA) (C20:4; n-6)

  10. Lipidstructures – Glycerophospholipids • Major lipid component of membranes • Varying polar headgroups and fatty acid chains • Variation in headgroup and fatty acid chains alter their properties  altered membrane properties • Some phosphoglyceride are directly modulating enzyme activity, f ex phosphpatidylserine and Proteinkinase C of the classical type

  11. Glycerophospholipids-variation in structure 30 – 35 differentfattyacidsarecommonlyidentified in glycerophospholipids

  12. Lipidfunctions in cellbiology The biologicalmembrane • Defines the cell and the cell organelles • Semipermeable – efflux and influx of polar molecules are controlled • Is the basis for energy metabolism – proton-gradients • Ensure a stable cellular environment • Provides a 2-D space for efficient chemical reaction • The lipids creates an optimal environment for protein function in the membrane  More than 300 lipid species are found in the plasma membrane

  13. Lipidfunctions in cellbiology Regulation of gene-transcription • Transcriptionalregulation of genes in glucose and fat metabolismarepartlycontrolled by lipidlevelsthroughlipid-activatedtranscription factors Example of lipidregulatedtranscription factors: The family of PeroxisomeProliferatorActivated- Receptors (PPAR) Binding of polyunsaturatedfattyacids, or structuresderived from polyunsaturatedfattyacidsarerequired for theiractivation. Picture from Cuzzòcrea , 2006

  14. Lipidfunctions in cellbiology Lipidsignalling – Lipidsareimportantintra- and extracellularsignallingmolecules Prostaglandin and leukotriensynthesis (Eicosanoids) Somelipidsignallingmolecules • Eicosanoids • Resolvins, Neuroprotectins • Diacylglycerol • Ceramide • Sphingosine-1-phosphate • Ceramide-1-phosphate • Phosphoinosotides • etc, etc Inflammation Vasoconstriction Gasticmucosalsecretion …. Plateletaggregation bloodclotting ….

  15. Lipidfunctions in cellbiology Lipidsignalling Example2: The ceramide / Sphingosine-1-P Rheostat Sphingosine Ceramide: Cell cycle arrest Terminal differentation Apoptosis Sphingosine-1-phosphate: Cell proliferation Prevent differentiation Sphingomyelin: Membrane lipid

  16. Lipidfunctions in cellbiology Lipidsignallingthroughdirectlipid protein interactions Examples: Protein kinase C – activated by diacylglycerol or ceramide (some types) Phosphoinositide Dependent Kinase– Activatedtrough binding to the membranelipidphosphatidylinositol-tris- phosphate Clinicalimplications:

  17. Insulin receptor IRS-1 PDK-1 PKB PI-3 K Effects of DAG and ceramide on insulin signalling DAG PKCθ Serine phosphorylation inhibits the interaction with the insulin-receptor Phosphorylation threonin34 inhibits the binding to PIP3 in the plasma membrane Dephosphorylation of serin473 deactivates PKB Ceramid PKC PP2A Powell et al (2003). Mol. Cell Biology. 23:7794-7808; Stratford et al (2004) J. Biol . Chem. 279:36608-15; Kim et al (2004) J. Clinical Inv. 114:823-827

  18. Fatty acid metabolism Acetyl-CoA ACC FFA FFA Mitochondria FAS b-oxidation ACS CPT I Acyl-CoA GPAT Acyl-Carnithin Palmitoyl-CoA Lyso-phosphatidate Palmital SPT Phosphatidate Sphingosine 1-P Diacylglycerol Phosphoglycerides Sphingosine FFA Ceramide DGAT Neutral glycolipids Sphingomyelin Gangliosides Triacylglycerol Lars I. Hellgren SBE-Symposium 2008

  19. Lipidomics Lipidcomposition Transcriptomes of lipidmetabolism Pathwayfluxes ”Downstream” effects of lipidchanges Data integration Models of howlipidomic alterations areinvolved in diseasepathologies New therapies

  20. The human plasma lipidome Quehenberger O et al. J. Lipid Res. 2010;51:3299-3305

  21. Examples on lipids, genes and pathway data http://www.lipidmaps.org

More Related